The Potential Impact of the Trans-Pacific Partnership Agreement on Health Equity, with Illustration From New Zealand

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Trans-Pacific Partnership (TPP). 2015. https://www.mfat.govt.nz/en/about-us/who-we-are/treaty-making-process/trans-pacific-partnership-tpp/. Accessed 13 Jan 2016.

  2. 2.

    Buse K, Mays N, Walt G. Making health policy. Maidenhead: McGraw-Hill Education (UK); 2012.

    Google Scholar 

  3. 3.

    Keating G, Freeman J, Macmillan A, Neuwelt P, Monasterio E. TPPA should not be adopted without a full, independent health assessment. N Z Med J. 2016;129:7–14.

    PubMed  Google Scholar 

  4. 4.

    Hirono K, Haigh F, Gleeson D, Harris P, Thow AM, Friel S. Is health impact assessment useful in the context of trade negotiations? A case study of the Trans Pacific Partnership Agreement. BMJ Open. 2016;6:e010339.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Labonté R, Schram A, Ruckert A. The Trans-Pacific Partnership: is it everything we feared for health? Int J Health Policy Manag. doi:10.15171/ijhpm.2016.41. Epub 2016 Apr 17.

  6. 6.

    Ruckert A, Schram A, Labonté R, Friel S, Gleeson D, Thow A-M. Policy coherence, health and the sustainable development goals: a health impact assessment of the Trans-Pacific Partnership. Crit Public Health. doi:10.1080/09581596.2016.1178379. Epub 2016 Apr 8.

  7. 7.

    New Zealand Ministry of Foreign Affairs and Trade. Trans-Pacific Partnership National Interest Analysis. 2016. https://www.tpp.mfat.govt.nz/assets/docs/TPP%20National%20Interest%20Analysis.pdf. Accessed 27 Jan 2016.

  8. 8.

    Whitehead M, Povall S, Loring B. The equity action spectrum: taking a comprehensive approach. Copenhagen: WHO Regional Office for Europe; 2014.

    Google Scholar 

  9. 9.

    Braveman P. Health disparities and health equity: concepts and measurement. Annu Rev Public Health. 2006;27:167–94.

    Article  PubMed  Google Scholar 

  10. 10.

    Victora CG, Vaughan JP, Barros FC. Explaining trends in inequities: evidence from Brazilian child health studies. Lancet. 2000;356:1093–8.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Lorenc T, Petticrew M, Welch V, Tugwell P. What types of interventions generate inequalities? Evidence from systematic reviews. J Epidemiol Community Health. 2013;67:190–3.

    Article  PubMed  Google Scholar 

  12. 12.

    McGill R, Anwar E, Orton L, Bromley H, Lloyd-Williams F, O’Flaherty M, et al. Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact. BMC Public Health. 2015;15:457.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Gillespie DOS, Allen K, Guzman-Castillo M, Bandosz P, Moreira P, McGill R, et al. The health equity and effectiveness of policy options to reduce dietary salt intake in England: policy forecast. PLoS One. 2015;10:e0127927.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Thomas S, Fayter D, Misso K, Ogilvie D, Petticrew M, Sowden A, et al. Population tobacco control interventions and their effects on social inequalities in smoking: systematic review. Tob Control. 2008;17:230–7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2015;387:176–87.

    Article  PubMed  Google Scholar 

  16. 16.

    Watts N, Adger WN, Agnolucci P, Blackstock J, Byass P, Cai W, et al. Health and climate change: policy responses to protect public health. Lancet. 2015;386:1861–914.

    Article  PubMed  Google Scholar 

  17. 17.

    Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Di Cesare M, Khang Y-HH, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381:585–97.

    Article  PubMed  Google Scholar 

  19. 19.

    Ministry of Health. Health loss in New Zealand: a report from the New Zealand Burden of Diseases, Injuries and Risk Factor Study 2006–20016. Wellington: Ministry of Health New Zealand; 2013.

    Google Scholar 

  20. 20.

    Baker MG, Barnard LT, Kvalsvig A, Verrall A, Zhang J, Keall M, et al. Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study. Lancet. 2012;379:1112–9.

    Article  PubMed  Google Scholar 

  21. 21.

    Baker M, McDonald A, Zhang J, Howden-Chapman P. Infectious diseases attributable to household crowding in New Zealand: a systematic review and burden of disease estimate. Wellington. 2013. http://www.healthyhousing.org.nz/wp-content/uploads/2010/01/HH-Crowding-ID-Burden-25-May-2013.pdf. Accessed 2 May 2016.

  22. 22.

    Ministry of Health. Annual update of key results 2013/14: New Zealand Health Survey. Wellington: Ministry of Health; 2014.

    Google Scholar 

  23. 23.

    Bennett H, Jones R, Keating G, Woodward A, Hales S, Metcalfe S. Health and equity impacts of climate change in Aotearoa-New Zealand, and health gains from climate action. N Z Med J. 2014;127:16–31.

    PubMed  Google Scholar 

  24. 24.

    Doctors Without Borders/Médecins Sans Frontières. Written submission to the Australian Parliament Joint Standing Committee on Treaties for consideration in the National Interest Analysis of the Trans-Pacific Partnership Agreement. 2016. http://www.msfaccess.org/sites/default/files/MSF_assets/Access/Docs/TPP_submission_AusParliament_ENG_2016.pdf. Accessed 2 May 2016.

  25. 25.

    Gleeson D. Biologics provisions in the final TPP text. 2015. https://tpplegal.files.wordpress.com/2015/12/biologics-provisions-in-the-final-tpp-text.pdf. Accessed 17 Apr 2016.

  26. 26.

    Gleeson D. Preliminary analysis of the final TPP Healthcare Transparency Annex: Annex 26-A: transparency and procedural fairness for pharmaceutical products and medical devices. 2015. pp. 1–13. http://infojustice.org/wp-content/uploads/2015/12/Gleeson-Preliminary-Analysis-Transparency-Annex-12-Dec-2015-1.pdf. Accessed 13 Jan 2016.

  27. 27.

    Gleeson D. The TPP’s final intellectual property (IP) chapter and access to medicines. 2015. http://aftinet.org.au/cms/sites/default/files/DEb%20Final%20IP%20chapter%20%20access%20to%20medicines%207%20Nov%202015.pdf. Accessed 13 Jan 2016.

  28. 28.

    Metcalfe S, Laking G, Arnold J. Variation in the use of medicines by ethnicity during 2006/07 in New Zealand: a preliminary analysis. N Z Med J. 2013;126:14–41.

    PubMed  Google Scholar 

  29. 29.

    Monasterio E, Gleeson D. The Trans Pacific Partnership Agreement: exacerbation of inequality for patients with serious mental illness. Aust N Z J Psychiatry. 2014;48:1077–80.

    Article  PubMed  Google Scholar 

  30. 30.

    United Nations Conference on Trade and Development. World investment report 2015: reforming international investment governance. Geneva: United Nations; 2015.

    Google Scholar 

  31. 31.

    Martin P. Australia faces $50m legal bill in cigarette plain packaging fight with Philip Morris. Sydney Morning Herald. 2015. http://www.smh.com.au/federal-politics/political-news/australia-faces-50m-legal-bill-in-cigarette-plain-packaging-fight-with-philip-morris-20150728-gim4xo.html. Accessed 13 Apr 2016.

  32. 32.

    World Health Organization. Confronting the tobacco epidemic in a new era of trade and investment liberalization. Geneva: World Health Organization; 2012.

    Google Scholar 

  33. 33.

    Snowdon W, Thow AM. Trade policy and obesity prevention: challenges and innovation in the Pacific Islands. Obes Rev. 2013;14:150–8.

    Article  PubMed  Google Scholar 

  34. 34.

    Schram A, Labonte R, Baker P, Friel S, Reeves A, Stuckler D. The role of trade and investment liberalization in the sugar-sweetened carbonated beverages market: a natural experiment contrasting Vietnam and the Philippines. Global Health. 2015;11:41.

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Wallach L. Only one of 44 attempts to use the GATT Article XX/GATS Article XIV “General Exception” has ever succeeded: replicating the WTO exception construct will not provide for an effective TPP general exception. PublicCitizen. 2015. https://www.citizen.org/documents/general-exception.pdf. Accessed 10 Feb 2016.

  36. 36.

    Miller D, Harkins C. Corporate strategy, corporate capture: food and alcohol industry lobbying and public health. Crit Soc Pol. 2010;30:564–89.

    Article  Google Scholar 

  37. 37.

    Oreskes N, Conway EM. Merchants of doubt: how a handful of scientists obscured the truth on issues from tobacco smoke to global warming. London: Bloomsbury; 2012.

    Google Scholar 

  38. 38.

    Neuwelt PM, Gleeson D, Mannering B. Patently obvious: a public health analysis of pharmaceutical industry statements on the Trans-Pacific Partnership international trade agreement. Crit Public Health. 2016;26:159–72.

    Article  Google Scholar 

  39. 39.

    Crosbie E, Glantz SA. Tobacco industry argues domestic trademark laws and international treaties preclude cigarette health warning labels, despite consistent legal advice that the argument is invalid. Tob Control. 2012;23:1–10.

    Google Scholar 

  40. 40.

    O’Brien P, Gleeson D. Trans-Pacific Partnership Agreement (TPP): alcoholic beverages and health information/warning labels. 2015. https://tpplegal.files.wordpress.com/2015/12/tpp-and-alcohol-health-warnings-summary-nov-2015.pdf. Accessed 3 Apr 2016.

Download references

Author Contributions

All authors contributed to the overall approach. GK prepared the first draft. All authors revised the drafts and approved the final text.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Erik Monasterio.

Ethics declarations

The authors received no funding for this work from any source. GK, JF and EM are founding members of Doctors for Healthy Trade. RJ is co-convenor and JF and GK are Executive Board members of OraTaiao: The New Zealand Climate and Health Council. This work did not involve any human or animal subjects.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Keating, G., Jones, R., Monasterio, E. et al. The Potential Impact of the Trans-Pacific Partnership Agreement on Health Equity, with Illustration From New Zealand. Appl Health Econ Health Policy 14, 397–400 (2016). https://doi.org/10.1007/s40258-016-0252-3

Download citation

Keywords

  • Health Equity
  • Health Inequity
  • Health Impact Assessment
  • Investment Agreement
  • Sugar Beverage